Literature DB >> 698876

Transient unilateral blindness following general anaesthesia: case report.

K A Munn, R T Williams, C M Shafto.   

Abstract

A case is reported of transient unilateral blindness following general anaesthesia with a face mask. The most likely explanation for this is central retinal artery occlusion, either partial or complete, due to excessive pressure from the mask exerted on the globe. This pressure may be increased with the use of neoprene head straps as opposed to the more flexible and elastic rubber straps. Pressure from the strap over the carotid artery may be a factor in reducing the central retinal arterial pressure, thus making it more susceptible to occlusion by mask pressure.

Entities:  

Mesh:

Year:  1978        PMID: 698876     DOI: 10.1007/BF03006577

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  5 in total

1.  Corneal injuries during general anesthesia.

Authors:  J C Snow; B J Kripke; M L Norton; P Chandra; H A Woodcome
Journal:  Anesth Analg       Date:  1975 Jul-Aug       Impact factor: 5.108

2.  Unilateral blindness occurring during anesthesia for neurosurgical operations.

Authors:  R W HOLLENHORST; H J SVIEN; C F BENOIT
Journal:  AMA Arch Ophthalmol       Date:  1954-12

3.  Occlusion of the central retinal artery following anesthesia.

Authors:  I GIVNER; N JAFFE
Journal:  Arch Ophthal       Date:  1950-02

4.  Clinical, ophthalmoscopic and biological findings in systemic fat embolism. Pathogenetic theory and treatment in 30 cases.

Authors:  L Arbus; J Fabre; G Bechac; Y Lazorthes
Journal:  Acta Neurochir (Wien)       Date:  1973       Impact factor: 2.216

5.  Occlusion of the central retinal artery following retrobulbar hemorrhage.

Authors:  M O Goldsmith
Journal:  Ophthalmologica       Date:  1967       Impact factor: 3.250

  5 in total
  1 in total

1.  The laryngeal mask airway: clinical appraisal in 250 patients.

Authors:  J R Maltby; R G Loken; N C Watson
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.